Similar articles for PMID: 29936465

Year	Number of Results
1947	1
1992	1
1994	1
1995	1
1999	1
2000	2
2001	1
2002	1
2003	1
2005	2
2006	2
2007	8
2008	4
2009	4
2010	8
2011	6
2012	8
2013	6
2014	5
2015	7
2016	12
2017	8
2018	6
2020	4
2021	1
2022	2

1

A Specific Survival Score for Patients Receiving Local Therapy for Single Brain Metastasis from a Gynecological Malignancy.

Rades D, Dziggel L, Schild SE. Rades D, et al. In Vivo. 2018 Jul-Aug;32(4):825-828. doi: 10.21873/invivo.11314. In Vivo. 2018. PMID: 29936465 Free PMC article.

2

Local Therapies Can Improve Intracerebral Control in Patients with Cerebral Metastasis from Gynecological Cancers.

Dziggel L, Janssen S, Bajrovic A, Veninga T, Trang NT, Khoa MT, Schild SE, Rades D. Dziggel L, et al. Anticancer Res. 2016 Sep;36(9):4777-80. doi: 10.21873/anticanres.11035. Anticancer Res. 2016. PMID: 27630327

3

An Instrument to Guide Physicians when Estimating the Survival of Elderly Patients With Brain Metastasis from Gynecological Cancer.

Rades D, Nguyen T, Janssen S, Schild SE. Rades D, et al. Anticancer Res. 2020 Apr;40(4):2257-2260. doi: 10.21873/anticanres.14188. Anticancer Res. 2020. PMID: 32234922

4

An Instrument for Estimating the 6-Month Survival Probability After Whole-brain Irradiation Alone for Cerebral Metastases from Gynecological Cancer.

Janssen S, Hansen HC, Schild SE, Rades D. Janssen S, et al. Anticancer Res. 2018 Jun;38(6):3753-3756. doi: 10.21873/anticanres.12656. Anticancer Res. 2018. PMID: 29848738

5

Overall Survival After Whole-Brain Radiation Therapy for Intracerebral Metastases from Testicular Cancer.

Rades D, Dziggel L, Veninga T, Bajrovic A, Schild SE. Rades D, et al. Anticancer Res. 2016 Sep;36(9):4817-9. doi: 10.21873/anticanres.11042. Anticancer Res. 2016. PMID: 27630334

6

Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.

Dziggel L, Gebauer N, Bartscht T, Schild SE, Rades D. Dziggel L, et al. Anticancer Res. 2018 Apr;38(4):2391-2394. doi: 10.21873/anticanres.12488. Anticancer Res. 2018. PMID: 29599366

7

Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer.

Rades D, Fischer D, Veninga T, Stalpers LJ, Schild SE. Rades D, et al. Gynecol Oncol. 2009 Sep;114(3):506-8. doi: 10.1016/j.ygyno.2009.05.030. Epub 2009 Jun 21. Gynecol Oncol. 2009. PMID: 19540574

8

Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.

Bernhardt D, Adeberg S, Bozorgmehr F, Opfermann N, Hoerner-Rieber J, König L, Kappes J, Thomas M, Herth F, Heußel CP, Warth A, Debus J, Steins M, Rieken S. Bernhardt D, et al. J Neurooncol. 2017 Aug;134(1):205-212. doi: 10.1007/s11060-017-2510-0. Epub 2017 May 30. J Neurooncol. 2017. PMID: 28560661

9

Treatment of five or more brain metastases with stereotactic radiosurgery.

Hunter GK, Suh JH, Reuther AM, Vogelbaum MA, Barnett GH, Angelov L, Weil RJ, Neyman G, Chao ST. Hunter GK, et al. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1394-8. doi: 10.1016/j.ijrobp.2011.10.026. Epub 2011 Dec 29. Int J Radiat Oncol Biol Phys. 2012. PMID: 22209150

10

Prognostic effect of symptomatic extracranial lesions on survival of recursive partitioning analysis Class III brain metastatic patients treated with stereotactic radiotherapy.

Chen XJ, Xiao JP, Li XP, Jiang XS, Zhang Y. Chen XJ, et al. J Cancer Res Ther. 2016 Jan-Mar;12(1):215-20. doi: 10.4103/0973-1482.160925. J Cancer Res Ther. 2016. PMID: 27072240 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed